Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
2019 Guide to Medications for the Treatment of Diabetes Mellitus -

2019 Guide to Medications for the Treatment of Diabetes Mellitus (eBook)

John R. White (Herausgeber)

eBook Download: EPUB
2019
American Diabetes Association (Verlag)
978-1-58040-734-2 (ISBN)
Systemvoraussetzungen
59,99 inkl. MwSt
(CHF 58,60)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
Medications for the Treatment of Diabetes offers a bridge between drug handbooks and pharmacology texts. Focusing entirely on diabetes drugs, this reference is divided into two sections: 1) Drugs used to manage hyperglycemia and 2) Management of diabetic co-morbidities.

The first section includes:

-- Pharmacologic Therapy for Type 1 Diabetes

-- Management of Hyperglycemia in Type 1 DM– info from practical use of insulin, pathophysiology, treatment strategy

-- Insulins- RAIAs, Short-acting insulins, intermediate-acting insulins, LAIAs, Concentrated Insulins, Insulin pumps and patches, inhaled insulins, mixed and mixing insulin, use in Type 1, use in Type 2

-- Pharmacologic Therapy for Type 2 Diabetes

-- Management of Hyperglycemia in Type 2- brief overview, pathophysiology, treatment strategy, overview of medications

-- Biguanides

-- TZDs

-- SUs

-- Glinides

-- SGLT-2 Inhibitors

-- AGIs

-- DPP-IV inhibitors

-- GLP RAs

-- Amylin mimetics

-- BARs

-- DA-2 agonists

Each chapter in Section 1 includes:

1.Drug class overview and role in diabetes treatment

2.Pharmacology -- a. Mechanism of action, b. Pharmacokinetics

3.Treatment Advantages/Disadvantages -- a. General for the class, b.When applicable, a discussion of evidence that supports the benefits of using a particular drug in a class over another in the same class (eg, Avandia vs Actos)

4.Therapeutic Considerations -- a. Significant Warnings/Precautions, b. Special Populations, c. Pharmacogenomics, d. Adverse effects and monitoring, e. Drug Interactions, f. Dosage and administration

5.Table with Doses and Dose Adjustments

6.List of important combination products

7.References


The second section includes:

-- Cardiovascular Disease and Risk Management

-- Microvascular Complications and Foot Care

-- Medications for the Management of Hypertension

-- Medications for the Management of Hyperlipidemia

-- Antiplatelet Therapy

-- Medications for Smoking Cessation

-- Medications for the Management of Neuropathy (peripheral and autonomic)

-- Medications for the Management of Nephropathy

-- Medications for the Management of Retinopathy

-- Medications for the Management of Depression

-- Medications for the Management of Hypoglycemia

-- Medications for the Management of Obesity

-- Immunizations in Patients with Diabetes


Each chapter in Section 2 includes:


1.An overview of the condition or problem

2.Goals of treatment

3.Overview of the medications and rationale for the medications used for the problem

4.Overview of each class of medication

5.Overview of combination therapy -- a. first combination, b. second combination

6.Doses and Dose Adjustments for the more salient medications

7.List of important combination products

8.References

Volume Editor, John R. White Jr., is chair of the Department of Pharmacotherapy at the Washington State University College of Pharmacy. White is a licensed pharmacist and has a Doctor of Pharmacy (Pharm.D.) degree from Mercer University in Atlanta, GA, and completed a residency and a fellowship in pharmacokinetics/pharmacodynamics at the University of California, San Francisco. He has been affiliated with the WSU College of Pharmacy for more than 20 years. Extensively involved in diabetes research and education since 1987. He is a sought after lecturer on pharmocological research for the treatment of diabetes. In 1998 while a pharmacy professor at WSU, Dr. White completed the University of Washington’s physician assistant training.

Section I Drugs Used to Manage Hyperglycemia

Chapter 1- ADA Standards- Chapter 8- excerpt- Pharmacologic Therapy for Type 1 Diabetes

Chapter 2- Management of Hyperglycemia in Type 1 DM– info from practical use of insulin, pathophysiology, treatment strategy- J. Neumiller

Chapter 3- Insulins- RAIAs, Short-acting insulins, intermediate-acting insulins, LAIAs, Concentrated Insulins, Insulin pumps and patches, inhaled insulins, mixed and mixing insulin, use in Type 1, use in Type 2- J. Neumiller

Chapter 4- ADA Standards- Chapter 8- excerpt- Pharmacologic Therapy for Type 2 Diabetes

Chapter 5- Management of Hyperglycemia in Type 2- brief overview, pathophysiology, treatment strategy, overview of medications- J. White

Chapter 6- Biguanides- P. Odegard

Chapter 7- TZDs- P. Odegard

Chapter 8- SUs- L. Kroon

Chapter 9- Glinides- L. Kroon

Chapter 10- SGLT-2 Inhibitors- J. White

Chapter 11- AGIs- K. McKeirnan

Chapter 12- DPP-IV inhibitors-K. McKeirnan

Chapter 13- GLP RAs- J. Trujillo

Chapter 14-Amylin mimetics- J. Trujillo

Chapter 15- BARs- C. Buchman

Chapter 16- DA-2 agonists- C. Buchman


Section II Management of Co-morbidities

Chapter 17- ADA Standards- Chapter 9- Cardiovascular Disease and Risk Management

Chapter 18- ADA Standards- Chapter 9- Microvascular Complications and Foot Care

Chapter 19- Medications for the Management of Hypertension- C. Newsome

Chapter 20- Medications for the Management of Hyperlipidemia- C. Newsome

Chapter 21- Antiplatelet Therapy- M. Willson

Chapter 22- Medications for Smoking Cessation- A. Kim

Chapter 23- Medications for the Management of Neuropathy (peripheral and autonomic)- A. Kim

Chapter 24- Medications for the Management of Nephropathy- E. Tran

Chapter 25- Medications for the Management of Retinopathy- E. Tran

Chapter 26- Medications for the Management of Depression- M. Willson

Chapter 27- Medications for the Management of Hypoglycemia- M. Giruzzi

Chapter 28- Medications for the Management of Obesity- N. Giruzzi

Chapter 29- Immunizations in Patients with Diabetes- K. McKeirnan

EPUBEPUB (Adobe DRM)

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Das Wichtigste für Ärztinnen und Ärzte aller Fachrichtungen

von Ulrich Alfons Müller; Günther Egidi …

eBook Download (2021)
Urban & Fischer Verlag - Fachbücher
CHF 36,10